Subtopic Deep Dive
Epilepsy Genetics
Research Guide
What is Epilepsy Genetics?
Epilepsy Genetics studies genetic causes of epilepsy, including monogenic mutations, polygenic risks, and gene-environment interactions via genome-wide association studies and functional analyses.
Key advances identify de novo mutations in epileptic encephalopathies (Allen et al., 2013, 1524 citations) and sodium channel mutations like SCN1A (Meisler, 2005, 495 citations). Classifications integrate genetic etiologies, as in ILAE updates (Scheffer et al., 2017, 4670 citations). Over 150 SCN1A mutations link to epilepsy phenotypes.
Why It Matters
Genetic findings enable precision diagnostics for monogenic epilepsies, guiding targeted therapies like sodium channel blockers for SCN1A mutations (Meisler, 2005). Polymorphisms in ABCB1 associate with multidrug resistance, informing pharmacogenomics (Siddiqui et al., 2003, 650 citations). Classifications aid syndrome identification in neonates and children, improving treatment outcomes (Zuberi et al., 2022, 754 citations; Specchio et al., 2022, 786 citations).
Key Research Challenges
Heterogeneous Genetic Phenotypes
Epilepsies show variable expressivity from identical mutations, complicating genotype-phenotype mapping (Scheffer, 1997, 747 citations). Familial studies reveal broad clinical spectra in generalized epilepsy with febrile seizures plus. Functional validation of rare variants remains resource-intensive.
De Novo Mutation Detection
Sporadic de novo mutations drive many epileptic encephalopathies, requiring high-depth sequencing (Allen et al., 2013, 1524 citations). Trio-based exome sequencing identifies loss-of-function variants, but interpretation challenges persist. Low recurrence rates hinder causal confirmation.
Drug Resistance Mechanisms
ABCB1 polymorphisms link to antiepileptic drug efflux, causing resistance in 30% of patients (Siddiqui et al., 2003, 650 citations). Polygenic factors interact with transporters, evading standard therapies (Löscher et al., 2020, 775 citations). Validating multifactorial models demands large cohorts.
Essential Papers
<scp>ILAE</scp> classification of the epilepsies: Position paper of the <scp>ILAE</scp> Commission for Classification and Terminology
Ingrid E. Scheffer, Samuel F. Berkovic, Giuseppe Capovilla et al. · 2017 · Epilepsia · 4.7K citations
Summary The International League Against Epilepsy ( ILAE ) Classification of the Epilepsies has been updated to reflect our gain in understanding of the epilepsies and their underlying mechanisms f...
De novo mutations in epileptic encephalopathies
Andrew S. Allen · 2013 · Nature · 1.5K citations
A developmental and genetic classification for malformations of cortical development: update 2012
A. James Barkovich, Renzo Guerrini, Ruben Kuzniecky et al. · 2012 · Brain · 1.0K citations
Increasing recognition of malformations of cortical development and continuing improvements in imaging techniques, molecular biologic techniques, and knowledge of mechanisms of brain development ha...
Seizures and Epilepsy: An Overview for Neuroscientists
Carl E. Stafstrom, Lionel Carmant · 2015 · Cold Spring Harbor Perspectives in Medicine · 879 citations
Epilepsy is one of the most common and disabling neurologic conditions, yet we have an incomplete understanding of the detailed pathophysiology and, thus, treatment rationale for much of epilepsy. ...
International League Against Epilepsy classification and definition of epilepsy syndromes with onset in childhood: Position paper by the ILAE Task Force on Nosology and Definitions
Nicola Specchio, Elaine Wirrell, Ingrid E. Scheffer et al. · 2022 · Epilepsia · 786 citations
Abstract The 2017 International League Against Epilepsy classification has defined a three‐tier system with epilepsy syndrome identification at the third level. Although a syndrome cannot be determ...
Drug Resistance in Epilepsy: Clinical Impact, Potential Mechanisms, and New Innovative Treatment Options
Wolfgang Löscher, Heidrun Potschka, Sanjay M. Sisodiya et al. · 2020 · Pharmacological Reviews · 775 citations
ILAE classification and definition of epilepsy syndromes with onset in neonates and infants: Position statement by the ILAE Task Force on Nosology and Definitions
Sameer M. Zuberi, Elaine Wirrell, Elissa Yozawitz et al. · 2022 · Epilepsia · 754 citations
Abstract The International League Against Epilepsy (ILAE) Task Force on Nosology and Definitions proposes a classification and definition of epilepsy syndromes in the neonate and infant with seizur...
Reading Guide
Foundational Papers
Start with Allen et al. (2013, 1524 citations) for de novo mutations in encephalopathies, Scheffer (1997, 747 citations) for familial phenotypes, and Meisler (2005, 495 citations) for SCN1A mechanisms to build genetic etiology basics.
Recent Advances
Study Scheffer et al. (2017, 4670 citations) for ILAE classification integrating genetics, Zuberi et al. (2022, 754 citations) for neonatal syndromes, and Specchio et al. (2022, 786 citations) for childhood onset.
Core Methods
Exome/trio sequencing (Allen et al., 2013), polymorphism genotyping (Siddiqui et al., 2003), ILAE genetic-phenotypic classification (Scheffer et al., 2017), and functional mutation assays (Meisler, 2005).
How PapersFlow Helps You Research Epilepsy Genetics
Discover & Search
Research Agent uses searchPapers and exaSearch to find epilepsy genetics papers like 'De novo mutations in epileptic encephalopathies' (Allen et al., 2013), then citationGraph reveals connections to SCN1A works (Meisler, 2005) and findSimilarPapers uncovers related de novo studies.
Analyze & Verify
Analysis Agent applies readPaperContent to extract mutation data from Allen et al. (2013), verifies claims with CoVe against ILAE classifications (Scheffer et al., 2017), and runs PythonAnalysis for statistical validation of variant frequencies using pandas on cohort data; GRADE scores evidence strength for monogenic claims.
Synthesize & Write
Synthesis Agent detects gaps in polygenic risk modeling post-Allen et al. (2013), flags contradictions between ABCB1 resistance studies (Siddiqui et al., 2003) and newer reviews; Writing Agent uses latexEditText, latexSyncCitations for Scheffer (1997), and latexCompile to generate manuscripts with exportMermaid for mutation pathway diagrams.
Use Cases
"Run statistical analysis on de novo mutation rates in epileptic encephalopathies from recent cohorts."
Research Agent → searchPapers('de novo mutations epilepsy') → Analysis Agent → readPaperContent(Allen 2013) → runPythonAnalysis(pandas cohort stats, matplotlib plots) → researcher gets verified mutation frequency CSV with p-values.
"Draft LaTeX review on SCN1A mutations in epilepsy genetics."
Synthesis Agent → gap detection(SCN1A literature) → Writing Agent → latexEditText(structured review) → latexSyncCitations(Meisler 2005, Scheffer 2017) → latexCompile → researcher gets compiled PDF with inline citations and figures.
"Find code for epilepsy GWAS analysis from papers."
Research Agent → searchPapers('epilepsy GWAS code') → paperExtractUrls → paperFindGithubRepo → githubRepoInspect → researcher gets annotated GitHub repos with pipelines for polygenic risk scoring.
Automated Workflows
Deep Research workflow scans 50+ epilepsy genetics papers via searchPapers, structures reports on monogenic vs. polygenic etiologies with GRADE grading (Allen et al., 2013 forward citations). DeepScan applies 7-step CoVe to validate ABCB1 polymorphism impacts (Siddiqui et al., 2003). Theorizer generates hypotheses on gene-environment interactions from Scheffer (1997) and Löscher (2020).
Frequently Asked Questions
What defines Epilepsy Genetics?
Epilepsy Genetics examines monogenic mutations like SCN1A, de novo variants in encephalopathies, and polygenic risks via sequencing and GWAS.
What are key methods in Epilepsy Genetics?
Exome sequencing detects de novo mutations (Allen et al., 2013), trio analysis confirms causality, and functional assays validate sodium channel defects (Meisler, 2005).
What are foundational papers?
Allen et al. (2013, 1524 citations) on de novo mutations, Scheffer (1997, 747 citations) on febrile seizure genetics, and Siddiqui et al. (2003, 650 citations) on ABCB1 resistance.
What open problems exist?
Mapping polygenic risks beyond monogenic cases, resolving variable phenotypes (Scheffer, 1997), and overcoming drug resistance via multifactorial genetics (Löscher et al., 2020).
Research Epilepsy research and treatment with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Epilepsy Genetics with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Epilepsy research and treatment Research Guide